Loading...

AI Integration And Telehealth Expansion Will Transform The Healthcare Industry

Published
28 Aug 24
Updated
04 Oct 25
AnalystConsensusTarget's Fair Value
US$69.50
2.7% overvalued intrinsic discount
04 Oct
US$71.38
Loading
1Y
61.0%
7D
-2.4%

Author's Valuation

US$69.52.7% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on04 Oct 25
Fair value Increased 1.21%

Doximity's analyst price target has increased from $68.67 to $69.50 per share. This change reflects analysts' positive view on strong business momentum, promising AI initiatives, and a conservative outlook for fiscal 2026 revenue growth.

Shared on13 Sep 25
Fair value Increased 1.15%

Doximity’s price target was raised modestly to $68.67 as analysts pointed to robust Q1 results, AI-driven strategy enhancements, and conservative guidance as drivers of sustained business momentum. Analyst Commentary Bullish analysts cite strong Q1 results and upwardly revised guidance as evidence of solid business momentum.

Shared on10 Aug 25
Fair value Increased 7.38%

Doximity’s fair value outlook has improved as reflected by a higher consensus price target, despite a notable contraction in net profit margin and a rising future P/E multiple signaling higher growth expectations. What's in the News Doximity provided revenue guidance for FY26 of $628–636 million and Q2 FY26 of $157–158 million.

Shared on07 May 25
Fair value Decreased 15%

Shared on30 Apr 25
Fair value Decreased 1.84%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 2.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 3.57%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 19%

AnalystConsensusTarget has increased revenue growth from 10.1% to 12.3% and increased profit margin from 33.2% to 40.3%.